Pancreatic Cancer Risk Lowered with Aspirin Use

logo1267406_md

A study presented at the American Association of Cancer Research in Florida from April 2 to 6, concluded that there was a significant reduction in pancreatic cancer risk for those individuals using aspirin at least once a month. Although this was a large collaborative study the results are preliminary according to the researcher and widespread use of aspirin without medical consultation is discouraged.
In the study 904 patients with documented pancreatic cancer were compared with 1,224 healthy patients. All were at least 55 years of age and reported their use of aspirin, NSAIDs and acetaminophen by questionaire. Results showed that those who took aspirin at least monthly had a 26% reduced risk of pancreatic cancer compared to those who did not take regular aspirin. The results were also seen for those who took low dose aspirin for heart disease prevention at a 35% reduction. However, no benefits were seen for using non-aspirin NSAIDs or acetaqminophen.

More information is available at:
http://webcache.googleusercontent.com/search?q=cache:3mKguKWia2YJ:www.nlm.nih.gov/medlineplus/new

Tags: , , ,

Comments are closed.